Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major
Lancet
.
1984 Feb 18;1(8373):392-3.
doi: 10.1016/s0140-6736(84)90439-2.
Authors
R E Marcus
,
S C Davies
,
H M Bantock
,
S R Underwood
,
S Walton
,
E R Huehns
PMID:
6141447
DOI:
10.1016/s0140-6736(84)90439-2
No abstract available
Publication types
Letter
MeSH terms
Deferoxamine / therapeutic use*
Heart Diseases / chemically induced
Heart Diseases / drug therapy*
Humans
Iron / adverse effects*
Thalassemia / therapy*
Transfusion Reaction
Substances
Iron
Deferoxamine